| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.923772 |
| 003 | CaOODSP |
| 005 | 20240221143052 |
| 006 | m o d f |
| 007 | cr |n||||||||| |
| 008 | 230612t20242024onc o f|0| 0 eng d |
| 020 | |a9780660491042 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH164-352/2024E-PDF |
| 245 | 00|aPost-notice of compliance (NOC) changes : |bguidance for quality of veterinary drugs. |
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2024. |
| 264 | 4|c©2024 |
| 300 | |a1 online resource (iv, 63 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Changements survenus après l’avis de conformité [AC] : lignes directrices sur la qualité des médicaments vétérinaires. |
| 650 | 0|aDrug approval|zCanada. |
| 650 | 0|aVeterinary drugs|zCanada. |
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
| 775 | 08|tChangements survenus après l’avis de conformité [AC] : |w(CaOODSP)9.923773 |
| 856 | 40|qPDF|s1.42 MB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-352-2024-eng.pdf |
| 986 | |a230699 |